Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$98,390,870
-$23,517,041 QoQ
Shares Held
157,794
+0.0% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#82
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. REGN ranks #2 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,390,870 | 157,794 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $121,907,911 | 157,781 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $124,120,555 | 160,805 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $94,461,922 | 168,001 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $89,595,975 | 170,659 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $109,827,706 | 173,167 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $121,537,744 | 170,620 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $183,699,985 | 174,746 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $189,287,349 | 180,097 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $176,681,401 | 183,567 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $159,495,707 | 181,598 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $150,830,462 | 183,278 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $133,700,893 | 186,073 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $150,944,065 | 183,704 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $135,571,578 | 187,905 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $123,306,352 | 178,998 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $102,604,207 | 173,573 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $113,930,460 | 163,126 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $102,305,608 | 161,999 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $97,595,563 | 161,267 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $90,367,303 | 161,792 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $78,186,385 | 165,250 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $84,000,268 | 173,874 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $107,969,246 | 192,878 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $122,171,164 | 195,897 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $71,509,582 | 146,449 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||